Bio Innovation Conference | Conference Agenda
10
page-template,page-template-full_width,page-template-full_width-php,page,page-id-10,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive
 

Conference Agenda

october 7, 2019 •  bethesda north marriott hotel & conference center

    Monday, October 7, 2019

    11:30 am-4:00 pm

    BIO Partnering Meetings

    7:30 am Registration Open | Exhibit Hall Open | Breakfast and Networking
    7:30 am-9:30 am BIO Partnering Meetings
    8:30 am-8:40 am Welcome and Opening Remarks
    8:45 am-9:45 am
    (concurrent panel sessions)

    SESSION A

    Track 1

    Poised for Disruptive Innovation: Maryland’s Rising Cell & Gene Therapy Industry
    Maryland’s Center of Excellence

    Moderator:
    Jon Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio

    Panelists:
    Emily English, Ph.D., Chief Executive Officer, Gemstone Therapeutics
    Kimberly Noonan, Ph.D., Founder, Executive Vice President and Chief Scientific Officer, WindMIL Therapeutics
    William Rust, Ph.D., Chief Executive Officer and Co-Founder, Seraxis

    Track 2

    Alternative Funding Options for Launching Your Company
    Experts discuss different levels of early stage fundraising

    Moderator:
    Jeff Galvin, Chief Executive Officer and Founder, American Gene Technologies

    Panelists:
    Judy CostelloManaging Director, Economic Development, BioHealth Innovation
    Henry Ahn, SBIR/STTR Program Director, National Science Foundation
    Joseph Naft, Director, Maryland Industrial Partnerships (MIPS) Program
    Paul Silber, Founding Principal, Blu Venture Investors

    10:00 am – 11:00 am
    Sponsored by Maxcyte

    Keynote Address
    Hopes for a Cure – Gene Therapy for Sickle Cell Anemia

    Keynote Speaker:
    John F. Tisdale, M.D., Chief, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health

    11:15 am-12:15 pm
    (concurrent panel sessions)

    SESSION B

    Track 1

    The Future of Cells and Genes – How Now Becomes Then

    Moderator:
    Brad Stewart, Chief Executive Officer, Immunology Partners

    Panelists:
    Doug Doerfler, President and Chief Executive Officer, MaxCyte
    Lyndsey Scull, Vice President, Communications, Alliance for Regenerative Medicine

    Track 2

    Employment Opportunities Fulfilled
    The demand for life sciences job skills is growing rapidly in this region. Our roundtables will discuss opportunities and challenges while determining actions which can be taken to ensure workforce readiness and availability for the near-, mid- and long-term.

    Moderators:
    Sarah Sheppard, Director of Education and Workforce, Office of Strategic Industries and Entrepreneurship, Maryland Department of Commerce

    Roundtable Discussion Leaders:
    Shiva Fritsch, Senior Vice President of Human Resources, REGENXBIO
    Brian Gaines, Chief Executive Officer, Learning Undefeated
    Joseph Sanchez, Ph.D., Associate Director of Learning and Talent Development, AstraZeneca

    12:15 pm-1:30 pm
    Sponsored by Towson University

    Networking Lunch in the Exhibit Hall

    11:30 am-4:00 pm

    Bio Partnering Meetings

    1:30 pm-2:30 pm
    (concurrent panel sessions)

    SESSION C

    Track 1

    Novel Therapies, Regulatory Realities

    Moderator:
    Michael Druckman, Partner, Washington, D.C., Hogan Lovells

    Panelists:
    Julia Barrett, M.D., MPH, Senior Clinical Consultant, Biologics Consulting
    David Feigal, M.D., MPH, Partner, NDA Partners
    Randy Prebula, Partner, Washington, D.C., Hogan Lovells

    Track 2

    Strategic Market Planning for Capital and Commercialization
    Experts discuss key considerations and timing for market assessments to drive strategic partnering options and optimized commercial launch success

    Sponsored by

    Moderator:
    Steven Walker, Chief Business Officer and Commercial Strategist, Biologics Consulting

    Panelists:
    Brian AbrahamDirector, Market Access, Life Sciences, BDO
    Luis Gutierrez, Past President, Commercialization Services, Covance
    Ram Palanki, Pharm.D., Senior Vice President of Commercial Strategy and Operations, REGENXBIO
    Tyrell Rivers, Ph.D., Executive Director of Corporate Development, AstraZeneca

    2:45 pm-3:45 pm
    (concurrent panel sessions)

    SESSION D

    Track 1

    New Frontiers of Biomanufacturing
    As Maryland’s cell and gene therapy industry continues to grow, companies are continuously improving the quality and value of their life-saving products. Industry leaders will discuss the evolution of the manufacturing process, generating new product innovations, ongoing challenges and what does the future hold for this sector. 

    Sponsored by

    Moderator:
    John Walker, Manufacturers Extension Partnership Liaison, NIIMBL

    Panelists:
    Jeffrey Hung, Ph.D.,Chief Commercial Officer, Vigene Biosciences, Inc.
    Christopher McDonald, Vice President of Manufacturing, Kite Pharma
    Jon Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio
    Aaron Vernon
    , Vice President, Engineering and Supply Chain, Autolus

    Track 2

    Past Seed Stage to the Last Mile
    Experts discuss later stage fundraising opportunities

    Sponsored by

    Moderator:

    Linda Segal, Principal, The McCormick Group

    Panelists:
    Subhendu Basu, Ph.D.Chief Operating Officer, Adaptive Phage Therapeutics
    Diana Bernstein, Ph.D., Senior Associate, MRL Ventures
    Pete Buzy, President, Paragon Gene Therapy, Catalent Biologics
    R. Jacob Vogelstein, General Partner, Camden Partners

    4:00 pm-5:00 pm

    Keynote Address

    5:00 pm-6:00 pm

    Cocktail Reception

    STAY INFORMED. Join our mailing list to receive our email newsletter.